Publications

5539 Results

Compliance with adjuvant chemotherapy (ACT) in non-small lung cancer (NSCLC): NCIC-CTG BR.10/JBR.10.

Authors
N Alam;F Shepherd;T Winton;B Graham;D Johnson;R Livingston;J Rigas;M Whitehead;K Ding;L Seymour
Journal / Conference
Proc of the American Society of Clinical Oncology 22:633(#2547)
Year
2002
Research Committee(s)
Lung
Study Number(s)
JBR10

Late cardiac effects of adjuvant CMF vs CAF in women with node negative breast cancer treated on SWOG 8897: initial results from SWOG 9342

Authors
PA Ganz;SJ Green;L Hutchins;S Martino;J Gralow;R Livingston;KS Albain
Journal / Conference
Breast Cancer Research and Treatment 76(1):S157(#639)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-9342

ErbB-2 amplification, ErbB-1 expression and tamoxifen response in ER-positive metastatic breast cancer; a SWOG study

Authors
G Arpino;S Green;DC Allred;P Ravdin;D Lew;S Martino;CK Osborne;R Elledge
Journal / Conference
Breast Cancer Research and Treatment 76(1):S67(#232)
Year
2002
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Beta-catenin is commonly mutated in human gastric cancers with cyclin D overexpression.

Authors
J Wang;ONJ Kim;WM Clements;AA Sarnaik;B Liu;A Noffsinger;G Stemmermann;AM Lowy;CM Fenoglio-Preisor
Journal / Conference
Proc of the American Association for Cancer Research 93:90(#526)
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Mutation of the B-catenin gene is a frequent cause of Wnt pathway activation in gastric cancer.

Authors
WM Clements;J Wang;A Sarnaik;OJ Kim;JL Groden;C Fenoglio-Preiser;AM Lowy
Journal / Conference
Proc of the American Association for Cancer Research 93:111(#770)
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

The relationship of gleason sum and survival in patients with metastatic (M+) prostate cancer (CaP): analysis of SWOG 8894.

Authors
ED Crawford;G Miller;J Faulkner;C Tangen;IM Thompson;M Eisenberger;M Hussain
Journal / Conference
South Central Section of the AUA, 81st Annual Meetings :170(#31)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

HRQL outcomes in a phase II trial for patients with recurrent ovarian cancer: was palliation achieved?

Authors
CM Moinpour;B Lyons;S McCoy;GL Winakur;PY Liu;ML Rothenberg
Journal / Conference
Quality of Life Research 11(7):660(#157)
Year
2002
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9324

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.

Authors
SA Hundahl;JS Macdonald;J Benedetti;T Fitzsimmons
Journal / Conference
Annals of Surgical Oncology 9(3):278-286
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Bayesian cure rate models for malignant melanoma: a case-study of Eastern Cooperative Oncology Group trial E1690

Authors
MH Chen;DP Harrington;JG Ibrahim
Journal / Conference
Applied Statistics 51(part.2):135-150
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of Intergroup 0114

Authors
JE Tepper;M O'Connell;D Niedzwiecki;DR Hollis;AB Benson III;B Cummings;LL Gunderson;JS Macdonald;JA Martenson;RJ Mayer
Journal / Conference
Journal of Clinical Oncology 20(7):1744-1750
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9040